Trial of Deferiprone in Parkinson’s DiseaseDavid Devos, Christoph Scherfler, Petr Dušek et al.|New England Journal of Medicine|2022Cited by 226
Arm swing as a potential new prodromal marker of Parkinson's diseaseAnat Mirelman, Nir Giladi, Hagar Bernad‐Elazari et al.|Movement Disorders|2016Cited by 180
Penetrance estimate of <i>LRRK2</i> p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestryAnnie Lee, Karen Marder, Yuanjia Wang et al.|Movement Disorders|2017Cited by 170
Inflammatory profile in LRRK2-associated prodromal and clinical PDKathrin Brockmann, Walter Maetzler, Anja Apel et al.|Journal of Neuroinflammation|2016Cited by 78
Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter studyNúria Guillén, Albert Lladó, José Contador et al.|European Archives of Psychiatry and Clinical Neuroscience|2023Cited by 14